Intellia Therapeutics Announces Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. LLY
5. FLG
6. META
7. FICO
8. GMAB
9. QQQ
10. TSLA

Go back to Intellia Therapeutics Announces Third Quarter 2020 Financial Results

Intellia Therapeutics (NTLA) PT Raised to $39 at Raymond James

November 5, 2020 12:52 PM EST

Raymond James analyst Steven Seedhouse raised the price target on Intellia Therapeutics (NASDAQ: NTLA) to $39.00 (from $27.00) while maintaining a Outperform rating.

... More

Intellia Therapeutics (NTLA) Tops Q3 EPS by 12c, Revenues Beat

November 5, 2020 8:13 AM EST

Intellia Therapeutics (NASDAQ: NTLA) reported Q3 EPS of ($0.47), $0.12 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $22.22 million versus the consensus estimate of $15.58 million.

We are very pleased with the recent regulatory... More